{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:11:00Z","timestamp":1788408660154,"version":"build-2803163510"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/aci.0b013e3282efb726","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T17:14:42Z","timestamp":1236186882000},"page":"436-441","source":"Crossref","is-referenced-by-count":147,"title":["Clinical grading of vernal keratoconjunctivitis"],"prefix":"10.1097","volume":"7","author":[{"given":"Stefano","family":"Bonini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Sacchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Mantelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Lambiase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210128","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1067\/mai.2000.111238","article-title":"Allergic and immunologic disorders of the eye. Part II: Ocular allergy","volume":"106","author":"Bielory","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"R2-13-20210128","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0161-6420(00)00092-0","article-title":"Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term follow-up","volume":"107","author":"Bonini","year":"2000","journal-title":"Ophthalmology"},{"key":"R3-13-20210128","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-0420.2005.00622.x","article-title":"Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study","volume":"84","author":"Leonardi","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"R4-13-20210128","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1350-9462(02)00006-X","article-title":"Vernal keratoconjunctivitis: pathogenesis and treatment","volume":"21","author":"Leonardi","year":"2002","journal-title":"Prog Retin Eye Res"},{"key":"R5-13-20210128","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2222.2003.01538.x","article-title":"Atopy and serum eosinophil cationic protein in 110 white children with vernal keratoconjunctivitis: differences between tarsal and limbal forms","volume":"33","author":"Pucci","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"R6-13-20210128","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/eye.1989.63","article-title":"Limbal vernal keratoconjunctivitis: clinical characteristics and immunoglobulin E expression compared with palpebral vernal","volume":"3","author":"Tuft","year":"1989","journal-title":"Eye"},{"key":"R7-13-20210128","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.eye.6700675","article-title":"Vernal keratoconjunctivitis","volume":"18","author":"Bonini","year":"2004","journal-title":"Eye"},{"key":"R8-13-20210128","first-page":"394","article-title":"Corneal complications of vernal catarrh","volume":"13","author":"Iqbal","year":"2003","journal-title":"J Coll Physicians Surg Pak"},{"key":"R9-13-20210128","first-page":"88","article-title":"Ocular complications of vernal keratoconjunctivitis","volume":"34","author":"Tabbara","year":"1999","journal-title":"Can J Ophthalmol"},{"key":"R10-13-20210128","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bjo.83.2.180","article-title":"Efficacy of nedocromil 2% versus fluorometholone 0.1%: a randomised, double masked trial comparing the effects on severe vernal keratoconjunctivitis","volume":"83","author":"Tabbara","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"R11-13-20210128","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/eye.1998.67","article-title":"Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal keratoconjunctivitis","volume":"12","author":"Akman","year":"1998","journal-title":"Eye"},{"key":"R12-13-20210128","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00006324-199107000-00010","article-title":"Treatment of vernal keratoconjunctivitis: a retrospective clinical case study. Wallace F. Molinari Ocular Pharmacology Award","volume":"68","author":"Coutu","year":"1991","journal-title":"Optom Vis Sci"},{"key":"R13-13-20210128","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.eye.6702136","article-title":"Corneal topographic response to intraocular pressure reduction in patients with vernal keratoconjunctivitis and steroid-induced glaucoma","volume":"21","author":"Dada","year":"2007","journal-title":"Eye"},{"key":"R14-13-20210128","first-page":"25","article-title":"Vernal keratoconjunctivitis in Thailand","volume":"21","author":"Kosrirukvongs","year":"2003","journal-title":"Asian Pac J Allergy Immunol"},{"key":"R15-13-20210128","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/112067210101100203","article-title":"Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis","volume":"11","author":"Verin","year":"2001","journal-title":"Eur J Ophthalmol"},{"key":"R16-13-20210128","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2222.1999.00501.x","article-title":"Nedocromil sodium eye drops are more effective than sodium cromoglycate eye drops for the long-term management of vernal keratoconjunctivitis","volume":"29","author":"Verin","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"R17-13-20210128","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/106002809603000519","article-title":"Lodoxamide in vernal keratoconjunctivitis","volume":"30","author":"Lee","year":"1996","journal-title":"Ann Pharmacother"},{"key":"R18-13-20210128","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0161-6420(88)33201-X","article-title":"Evaluation of topical cromolyn sodium in the treatment of vernal keratoconjunctivitis","volume":"95","author":"Foster","year":"1988","journal-title":"Ophthalmology"},{"key":"R19-13-20210128","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.clinthera.2005.09.013","article-title":"Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial","volume":"27","author":"Avunduk","year":"2005","journal-title":"Clin Ther"},{"key":"R20-13-20210128","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1517\/14656566.5.9.1979","article-title":"A review of olopatadine for the treatment of ocular allergy","volume":"5","author":"Abelson","year":"2004","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl 2","key":"R21-13-20210128","first-page":"644","article-title":"Treatment of severe vernal keratoconjunctivitis with cyclosporine A eyedrops","volume":"20","author":"BenEzra","year":"1988","journal-title":"Transplant Proc"},{"key":"R22-13-20210128","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/eye.1997.14","article-title":"Topical cyclosporin A 2% in the treatment of vernal keratoconjunctivitis","volume":"11","author":"Mendicute","year":"1997","journal-title":"Eye"},{"key":"R23-13-20210128","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9394(14)77061-8","article-title":"Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis","volume":"110","author":"Secchi","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"R24-13-20210128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/eye.2001.10","article-title":"Topical cyclosporin A in the management of vernal keratoconjunctivitis","volume":"15","author":"Gupta","year":"2001","journal-title":"Eye"},{"key":"R25-13-20210128","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0161-6420(91)32069-4","article-title":"Topical cyclosporine in vernal keratoconjunctivitis","volume":"98","author":"Bleik","year":"1991","journal-title":"Ophthalmology"},{"key":"R26-13-20210128","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1399-3038.2006.00427.x","article-title":"Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood","volume":"17","author":"Spadavecchia","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"key":"R27-13-20210128","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1081-1206(10)61958-8","article-title":"Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis","volume":"89","author":"Pucci","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R28-13-20210128","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3129\/i06-061","article-title":"Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis","volume":"41","author":"Kilic","year":"2006","journal-title":"Can J Ophthalmol"},{"key":"R29-13-20210128","first-page":"5","article-title":"Current concepts in ocular allergy","volume":"67","author":"Friedlaender","year":"1991","journal-title":"Ann Allergy"},{"issue":"Suppl 78","key":"R30-13-20210128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1398-9995.2004.00570.x","article-title":"Atopic keratoconjunctivitis","volume":"59","author":"Bonini","year":"2004","journal-title":"Allergy"},{"key":"R31-13-20210128","first-page":"12","article-title":"Studies of allergic conjunctivitis","volume":"5","author":"Bonini","year":"1987","journal-title":"Chibret Int J"},{"key":"R32-13-20210128","first-page":"296","article-title":"IgE and non-IgE mechanisms in ocular allergy","volume":"71","author":"Bonini","year":"1993","journal-title":"Ann Allergy"},{"key":"R33-13-20210128","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0091-6749(05)80046-6","article-title":"Conjunctival hyperresponsiveness to ocular histamine challenge in subjects with vernal conjunctivitis","volume":"89","author":"Bonini","year":"1992","journal-title":"J Allergy Clin Immunol"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ACI.0b013e3282efb726","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:41:28Z","timestamp":1786038088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00130832-200710000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e3282efb726","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}